TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION
TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATION
批准号:
2700561
负责人:
PETER M GLAZER
金额:
$23.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-01 至 1999-04-30
中文摘要
描述:这项工作的总体目标是开发和测试新的
用遗传学的方法来检验三螺旋形成的假说
寡核苷酸可用于递送位点选择性DNA损伤,
哺乳动物细胞中的突变。 这项工作的具体目标是
开发新的模型来研究三螺旋介导的突变(基于
航天飞机载体技术),以研究物理参数
其在体外影响这些穿梭载体的靶向诱变,
研究影响TFO介导的DNA损伤和修复途径
突变,最后将工作扩展到研究TFO介导的突变
在小鼠的染色体基因中,而不是穿梭载体。
英文摘要
DESCRIPTION: The overal goal of the work is to develop and test novel
genetic methods to test the hypothesis that triple helix forming
oligonucleotides can be used to deliver site-selective DNA damage and
mutation in mammalian cells. The specific aims of the work are to
develop new models to study triple helix- mediated mutagenesis (based
upon shuttle vector technology), to investigate the physical parameters
which affect targeted mutagenesis upon these shuttle vectors in vitro,
to examine DNA damage and repair pathways which influence TFO mediated
mutation, and finally to extend the work to study TFO mediated mutation
in chromosomal genes of the mouse, rather than shuttle vectors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PNA Nanoparticles for Gene Editing In Vivo
-
批准号:10198735
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2019
-
负责人:PETER M GLAZER
-
依托单位:
PNA Nanoparticles for Gene Editing In Vivo
-
批准号:9804726
-
项目类别:
-
资助金额:$42.11万
-
财政年份:2019
-
负责人:PETER M GLAZER
-
依托单位:
PNA Nanoparticles for Gene Editing In Vivo
-
批准号:10414795
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2019
-
负责人:PETER M GLAZER
-
依托单位:
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung
-
批准号:10274829
-
项目类别:
-
资助金额:$75.68万
-
财政年份:2018
-
负责人:PETER M GLAZER
-
依托单位:
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung
-
批准号:10706300
-
项目类别:
-
资助金额:$114.48万
-
财政年份:2018
-
负责人:PETER M GLAZER
-
依托单位:
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies Supplement
-
批准号:10619840
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2018
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:9388067
-
项目类别:
-
资助金额:$77.33万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:10204894
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:10456727
-
项目类别:
-
资助金额:$98.49万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Novel DNA Repair Inhibitors for Cancer Therapy
-
批准号:9981673
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2017
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Biology Training Grant
-
批准号:10170726
-
项目类别:
-
资助金额:$44.14万
-
财政年份:2016
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Biology Training Grant
-
批准号:10394345
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2016
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Biology Training Grant
-
批准号:10599891
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2016
-
负责人:PETER M GLAZER
-
依托单位:
Bifunctional Antibodies for Melanoma Therapy
-
批准号:8755327
-
项目类别:
-
资助金额:$45.94万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
In vivo genomic editing of hematopoietic cells for HIV resistance
-
批准号:9110812
-
项目类别:
-
资助金额:$60.79万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
Bifunctional Antibodies for Melanoma Therapy
-
批准号:8916650
-
项目类别:
-
资助金额:$44.27万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
Yale Cancer Center NCTN
-
批准号:8605651
-
项目类别:
-
资助金额:$55.15万
-
财政年份:2014
-
负责人:PETER M GLAZER
-
依托单位:
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy
-
批准号:8500076
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2013
-
负责人:PETER M GLAZER
-
依托单位:
Cell-Penetrating Anti-DNA Antibody for Radiosensitization and Cancer Therapy
-
批准号:8826075
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:PETER M GLAZER
-
依托单位:
Novel triplex-engineered, BRCA1-mutated cell lines for research
-
批准号:8412753
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2012
-
负责人:PETER M GLAZER
-
依托单位:
国内基金
海外基金
小麦部分同源染色体(homoeologous chromosomes)间的定向重组
-
批准号:--
-
项目类别:--
-
资助金额:199万元
-
批准年份:2020
-
负责人:刘宝
-
依托单位: